Allianz Asset Management GmbH - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 168 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 3.79 and the average weighting 0.1%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$641,866
+45.2%
97,400
+245.5%
0.00%
Q4 2021$442,000
-8.7%
28,194
-0.0%
0.00%
Q3 2021$484,000
-46.6%
28,195
-33.1%
0.00%
-100.0%
Q2 2021$907,000
+56.9%
42,141
-24.5%
0.00%0.0%
Q1 2020$578,000
-72.9%
55,833
-57.1%
0.00%
-50.0%
Q4 2019$2,134,000
+183.0%
130,032
+129.0%
0.00%
+100.0%
Q3 2019$754,000
-61.9%
56,781
-59.5%
0.00%
-50.0%
Q2 2019$1,978,000
-24.3%
140,372
-1.2%
0.00%
-33.3%
Q1 2019$2,614,000
-30.0%
142,059
-0.6%
0.00%
-25.0%
Q4 2018$3,734,000
+9.7%
142,888
-3.7%
0.00%
+33.3%
Q3 2018$3,405,000
+31.9%
148,363
+9.5%
0.00%0.0%
Q2 2018$2,581,000
+12.5%
135,460
-0.6%
0.00%
+50.0%
Q1 2018$2,295,000
+14.1%
136,218
+2.9%
0.00%0.0%
Q4 2017$2,011,000
-16.0%
132,315
-1.1%
0.00%0.0%
Q3 2017$2,395,000
+8.9%
133,822
-0.8%
0.00%0.0%
Q2 2017$2,199,000
+21.3%
134,937
+4.2%
0.00%0.0%
Q1 2017$1,813,000
-18.8%
129,486
-7.6%
0.00%0.0%
Q4 2016$2,234,000
-11.9%
140,080
-8.1%
0.00%0.0%
Q3 2016$2,537,000
+370.7%
152,464
+216.7%
0.00%
+100.0%
Q2 2016$539,000
+149.5%
48,140
+107.2%
0.00%
Q1 2015$216,00023,2300.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Palo Alto Investors LP 4,525,476$74,263,0004.09%
ARMISTICE CAPITAL, LLC 2,828,000$46,407,0002.68%
Birchview Capital, LP 80,000$1,313,0000.95%
GLOBEFLEX CAPITAL L P 145,426$2,386,0000.45%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 231,733$3,803,0000.36%
361 CAPITAL LLC 77,630$1,274,0000.35%
CADENCE CAPITAL MANAGEMENT LLC 152,428$2,501,0000.27%
BOOTHBAY FUND MANAGEMENT, LLC 148,000$2,429,0000.21%
EMERALD ADVISERS, LLC 258,497$4,242,0000.18%
EMERALD MUTUAL FUND ADVISERS TRUST 251,730$4,131,0000.17%
View complete list of VANDA PHARMACEUTICALS INC shareholders